Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Using a novel method called optovolution, EPFL researchers used light to evolve ...
Americans are frustrated with the health care system for two reasons. First, it ...
We could be in for another big year of biotech M&A. A busy 2025, in both licensi...
China is becoming an increasingly influential player in the global biotech marke...
At AGBT’s close, Julianna LeMieux and Kevin Davies discuss announcements from th...
Researchers have developed a new form of highly sensitive CAR T cells, known as ...
In Phase I, 77 pretreated patients with advanced solid tumors harboring a TP53 Y...
City Therapeutics launched its first clinical program last fall, when it began a...
Conventional farming practices often rely on the use of nitrogenous fertilizers ...
In this webinar, The post De-Risking RNA Therapeutics with High-Resolution Sequ...
Amid growing demand for metabolic treatments, Novo Nordisk and Vivtex have struc...
The Medicare drug price “negotiation” process has entered its third year, with s...
Apheris's ADMET Network will combine proprietary datasets in a privacy-preservin...
VIR-5500 is a Phase I dual-masked T-cell engager (TCE) candidate designed to tar...
Using a massively parallel reporter assay to test more than 220,000 DNA variants...
Proposals to let decisions by other countries control American drug prices are i...
